Nova News: Press Releases

Nova StatStrip Glucose Hospital Meter System Receives FDA Clearance for Intensive Care Use

Posted .

Only glucose monitoring system FDA-cleared for use throughout all hospital settings, all professional healthcare settings, and all patient populations including critical care FOR IMMEDIATE RELEASE: September 25, 2014 Contact: Ron Newby, Director of Marketing Phone: (781) 894-0800     Waltham, MA – Nova Biomedical’s StatStrip Glucose Hospital Meter System is the first blood glucose monitoring… Read more »

Nova Biomedical Simplifies Critical Care Testing with Next Generation Blood Gas Analyzer

Posted .

Waltham, MA – Nova Biomedical simplifies critical care testing with Stat Profile Prime®, a new blood gas analyzer that combines the revolutionary micro-electronics of the consumer world with Nova’s innovative ZERØ™ maintenance cartridge technology for a smaller, faster, and less expensive critical care analyzer. Stat Profile Prime’s ZERØ™ maintenance cartridge technology consists of individual cartridges… Read more »

Nova to Hold Its 25th Annual Scholarship Awards Dinner and Fund Raiser on May 17th, 2014

Posted .

Waltham, MA (February 2nd, 2014) The Nova Scholarships were started in 1989. The Scholarship program includes two distinct scholarship funds: The Thomas Gross Scholarships, established in 1989, and the Frederick Spaziani Scholarship, established in 1992. Since the first Scholarship Awards in 1990, Nova has given a total of $1,899,000 in scholarships and awards. In 2014,… Read more »

Study demonstrates effective cell culture control and real‐time adjustment of metabolites for improved process control in development activities

Posted .

ABSTRACT: Current initiatives within the biopharmaceutical industry to adopt PAT (Process Analytical Technology) approaches in manufacturing, include activities in early process development. With adherent cell lines, online sampling for real‐time process monitoring and process adjustment is challenging due to the viscosity of the cell culture and potential blockages to sampling systems caused by microcarriers. In… Read more »

BioProfile FLEX Autosampler aids in significant productivity improvement in Genentech study.

Posted .

“This work demonstrates the application of a fully automated cell culture control, monitoring, and data processing system to achieve significant productivity improvement via dynamic feeding media optimization.” ABSTRACT: Current industry practices for large-scale mammalian cell cultures typically employ a standard platform fed-batch process with fixed volume bolus feeding. Although widely used, these processes are unable… Read more »

New Study Demonstrates Nova Max Plus Meter (SMBG) Is Most Accurate Glucose Meter

Posted .

Waltham, MA (September 22, 2011) – Nova Max® Plus proved to be more accurate than other leading brand self-monitoring blood glucose meters (SMBG) in a study presented September 14th, 2011 at the European Association for the Study of Diabetes (EASD). The study was performed by the Clinical Translational Research and Innovation Center, University of Ulster,… Read more »

Strong Growth Prompts Nova Biomedical to Increase Manufacturing Capability With Purchase of 80,000 Square-foot Facility

Posted .

Waltham, MA, January 2011 — Nova Biomedical today announced that, in response to rapid growth in its diabetes and whole blood point-of-care testing products business, it has purchased an additional 80,000 square-foot manufacturing/warehouse facility in Billerica, MA. According to Lou Borrelli, Nova Biomedical CFO, “This additional state of the art manufacturing facility will ensure that… Read more »

Nova Diabetes Care Offers Free Nova Max Link Meter for Medtronic MiniMed Paradigm Pump Users

Posted .

June 10, 2011, Waltham, Ma. On May 9, 2011, LifeScan, Inc., makers of the OneTouch® UltraLink brand of blood glucose monitoring systems, announced the termination of their exclusive agreement with Medtronic MiniMed to supply MiniMed Paradigm pump users in the U.S with LifeScan’s OneTouch UltraLink glucose meter. In response to this termination announcement, Nova Diabetes… Read more »